Department of Pharmaceutics, School of Pharmacy, Shenyang Pharmaceutical University, Wenhua RD103, Shenyang, Liaoning 110016, China.
School of Pharmacy, China Medical University, Puhe RD77, Shenyang North New Area, Shenyang, Liaoning 110122, China.
Acta Biomater. 2021 Oct 15;134:576-592. doi: 10.1016/j.actbio.2021.07.023. Epub 2021 Jul 17.
The purpose of this study was to investigate the delivery of poorly water-soluble non-steroidal anti-inflammatory drugs (NSAIDs) by carboxyl-functionalized mesoporous silica nanoparticles (MSN-COOH) with high specific surface area (S). In this study, MSN-COOH was prepared by collaborative self-assembly using cetyltrimethylammonium bromide (CTAB) as template and hydrolysis (3-triethoxyl-propyl) succinic anhydride (TESPSA) as co-structure auxiliary directing agent (CSDA). The drug delivery systems were constructed with NSAIDs including Nimesulide (NMS) and Indomethacin (IMC) as model drugs. Moreover, the characterization techniques, hemolysis and bio-adsorption testes, in vitro drug release and in vivo biological studies of MSN-COOH were also carried out. The characterization results showed that MSN-COOH is spheres with clearly visible irregular honeycomb nanopores and rough surface (S: 1257 m/g, pore volume (V): 1.17 cm/g). After loading NMS/IMC into MSN-COOH with high drug loading efficiency (NMS: 98.7 and IMC: 98.2%), most crystalline NMS and IMC converted to amorphous phase confirmed using differential scanning calorimeter (DSC) and X-ray power diffraction (XRD) analysis. Meanwhile, MSN-COOH significantly increased the dissolution of NMS and IMC compared with non-functionalized mesoporous silica nanoparticles (MSN), which was also confirmed by wettability experiments. The results of in vivo biological effects showed that MSN-COOH had higher bioavailability of NMS and IMC than MSN, and exerted strong anti-inflammatory effects by delivering more NMS and IMC in vivo. STATEMENT OF SIGNIFICANCE: This study successfully prepared MSNs-COOH (mesoporous silica nanoparticles modified with negatively charged carboxyl groups on the surface and in the pores) with high specific surface area and pore volume by using the negatively charged carboxyl group (hyd-TESPSA) and the positively charged CTAB self-assembled through electrostatic attraction under alkaline conditions. The drug delivery systems were constructed with Nimesulide (NMS) and Indomethacin (IMC) as model drugs. The results showed MSNs-COOH had high drug loading capacity and also exhibited good in vitro drug release properties. Interestingly, NMS loaded MSNs-COOH also had a potential pH responsive release effect. In vivo biological studies revealed that NMS/IMC loaded MSNs-COOH could evidently improve the bioavailability and played the strong anti-inflammatory effects.
这项研究的目的是探讨通过具有高比表面积 (S) 的羧基功能化介孔硅纳米粒子 (MSN-COOH) 递运疏水性非甾体抗炎药 (NSAIDs)。在这项研究中,MSN-COOH 是通过使用十六烷基三甲基溴化铵 (CTAB) 作为模板和水解 (3-三乙氧基丙基) 琥珀酸酐 (TESPSA) 作为共结构辅助导向剂 (CSDA) 的协同自组装制备的。药物递送系统由 NSAIDs 构建,包括尼美舒利 (NMS) 和吲哚美辛 (IMC) 作为模型药物。此外,还对 MSN-COOH 的表征技术、溶血和生物吸附试验、体外药物释放和体内生物学研究进行了研究。表征结果表明,MSN-COOH 是具有明显可见不规则蜂窝纳米孔和粗糙表面的球体 (S:1257 m/g,孔体积 (V):1.17 cm/g)。将 NMS/IMC 负载到具有高载药效率的 MSN-COOH 中 (NMS:98.7%和 IMC:98.2%) 后,使用差示扫描量热法 (DSC) 和 X 射线粉末衍射 (XRD) 分析证实,大多数结晶 NMS 和 IMC 转化为非晶相。同时,与非功能化介孔硅纳米粒子 (MSN) 相比,MSN-COOH 显著提高了 NMS 和 IMC 的溶解度,润湿性实验也证实了这一点。体内生物效应的结果表明,MSN-COOH 使 NMS 和 IMC 的生物利用度高于 MSN,并通过在体内传递更多的 NMS 和 IMC 发挥了强大的抗炎作用。研究意义:本研究成功制备了具有高比表面积和孔体积的 MSNs-COOH(表面和孔中带负电荷的羧基修饰的介孔硅纳米粒子),方法是在碱性条件下通过静电吸引使带负电荷的羧基(hyd-TESPSA)和带正电荷的 CTAB 自组装。药物递送系统由尼美舒利 (NMS) 和吲哚美辛 (IMC) 作为模型药物构建。结果表明,MSNs-COOH 具有高载药能力,并且表现出良好的体外药物释放性能。有趣的是,负载 NMS 的 MSNs-COOH 还具有潜在的 pH 响应释放效果。体内生物学研究表明,负载 NMS/IMC 的 MSNs-COOH 可以明显提高生物利用度并发挥强大的抗炎作用。